Sensei Biotherapeutics

Last updated: September 13, 2024

John K. Celebi, CEO
John K. Celebi, CEO
USA | Funding: $58.5M (+)

Website: https://www.senseibio.com/

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.